Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China

Abstract

AbstractA concern of reverse causation exists about the association between nasopharyngeal carcinoma (NPC) prognosis and body mass index (BMI) at diagnosis, while the prognostic impact of BMI measured years before diagnosis is unknown. Therefore, we investigated associations of prediagnosis and pretreatment BMI and body shape on NPC mortality. From a population‐based patient cohort in southern China between 2010 and 2013, we included 2526 incident NPC cases with prospective follow‐up through 2018. We assessed the associations of BMI and body shape at age 20 years, 10 years before diagnosis, and at diagnosis with NPC mortality, combining strategies of stratification and statistical adjustment to minimize reverse causation. We observed 25% lower all‐cause mortality (hazard ratio [HR] 0.75, 95% confidence interval [CI]: 0.64‐0.89) and 25% lower NPC‐specific mortality (HR 0.75, 95% CI: 0.61‐0.91) among overweight vs normal‐weight NPC cases at diagnosis. Lean body shapes 1 and 2 at diagnosis were associated with 68% and 23% higher all‐cause mortality, respectively, compared to normal body shape 3. No effect modification by cancer stage was detected for associations with all‐cause or NPC‐specific mortality. Associations with BMI and body shape 10 years before diagnosis were similar but attenuated, while body size and shape at age 20 were not associated with mortality. Being overweight at diagnosis decreased mortality, and thinner body shape increased mortality, compared to normal weight/body shape. These associations may be due to poorer nutrition and treatment intolerance, resulting in treatment discontinuation and worse survival outcomes.